Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HHS vs HNI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HNI Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 8–2 Matrix Metrics)

HNI Overall Winner 6-Pillar Tally: HHS 0 – 5 HNI (1 Tie) Matrix Metrics: HHS 2 – 8 HNI

As of Nov 16, 2026, HNI Corporation (HNI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas HNI carries 49.8/100 (HOLD) at $48.48 (10.3x Forward P/E, 6.6% operating margin).

  • Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. HNI 49.8/100 HOLD), HNI captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (6.6% vs. -3.2% operating margin) and revenue trajectory (+132.9% vs. -1.7% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HHS vs HNI
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
TTM Revenue $155M
Forward P/E 14.3x
Beta / 30D Vol 0.49β · 46% Vol
Unified Composite Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.2 · SMA20: $3.95 · SMA50: $4.26
HNI NYSE Head-to-Head Winner
HNI Corporation
Office Furniture (No Wood)
$48.48
+0.34% 1D
Market Cap $3.5B
TTM Revenue $2.10B
Forward P/E 10.3x
Beta / 30D Vol 0.86β · 38% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 45.0 Fund 43.0 Flow 50.0 Mom 31.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 52.5 · SMA20: $48.09 · SMA50: $47.29

6-Pillar Scorecard Institutional Category Breakdown (HHS 0 – 5 HNI)

Columns: Metric · HHS · HNI
1. Valuation Multiples HNI
Forward P/E 14.3x 10.3x
Trailing P/E 14.3x N/M
PEG Ratio 1.19x 0.69x
EV / Revenue 0.3x 1.7x
2. Growth & Scale HNI
Revenue Growth (YoY) -1.7% +132.9%
Earnings Growth (YoY) -90.3% +39.8%
TTM Revenue (USD) $155M $2.10B
Market Cap $30.0M $3.5B
3. Profitability & Quality HNI
Gross Margin 16.1% 42.1%
Operating Margin -3.2% 6.6%
Net Profit Margin -3.7% 1.0%
Return on Equity (ROE) -30.4% 3.9%
4. Balance Sheet & Cash Flow HNI
Cash Generation (TTM) -$4.5M $223M EBITDA
Cash Flow Margin -2.9% 10.7% EBITDA Mgn
Net Cash / Leverage $17M Net Debt (1.10x D/E) $25.86 Book/Sh · 3.9% ROE
Dividend Yield None (0.00%) 2.82%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 38.5% (45th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat HNI
OpEx & R&D Intensity 19.3% of Rev ($30M) 35.5% of Rev ($744M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Conglomerates Operator Furnishings, Fixtures & Appliances Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HHS (2) vs HNI (8)
Institutional Metric HHS HNI Criterion Row Edge
Market Capitalization
Scale
$30.0M $3.5B Larger Scale HNI
Trailing P/E Ratio
Valuation
14.3x N/M Lower Multiple HHS
Forward P/E Ratio
Valuation
14.3x 10.3x Lower Multiple HNI
Revenue Growth (YoY)
Growth
-1.7% +132.9% Higher Growth HNI
Operating Margin (TTM)
Profitability
-3.2% 6.6% Higher Margin HNI
Net Profit Margin
Profitability
-3.7% 1.0% Higher Margin HNI
Return on Equity (ROE)
Capital Efficiency
-30.4% 3.9% Higher ROE HNI
52-Week Range Position
Momentum
69% ($2–$5) 82% ($29–$53) Stronger Trend HNI
Beta / 30D Volatility
Risk Regime
0.49β · 46% Vol 0.86β · 38% Vol Lower Realized Risk HNI
Unified Institutional Score
Composite Signal
61.8 / 100 (BUY) 49.8 / 100 (HOLD) Higher Composite HHS
Trailing 12M Revenue (USD)
Operating Scale
$155M $2.10B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
16.1% 42.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.19x PEG · 0.3x EV/Rev 0.69x PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$4.5M ($17M Net Debt (1.10x D/E)) $223M EBITDA ($25.86 Book/Sh · 3.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HNI +13.94 pp
HHS: -10.49% · HNI: +3.45%
3M Horizon HNI +5.77 pp
HHS: -3.76% · HNI: +2.01%
6M Horizon HNI +8.06 pp
HHS: +36.17% · HNI: +44.23%
1Y Horizon HHS +10.57 pp
HHS: +34.74% · HNI: +24.17%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs HNI. Trailing 12-month operating profitability (HHS -3.2% vs HNI 6.6%) and valuation multiples (HHS 14.3x vs HNI 10.3x Forward P/E) are benchmarked directly in Pillar 4 below.

HHS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$155M
Gross Margin16.1%
Op. Margin-3.2%
ROE / Fwd P/E-30.4% · 14.3x
HNI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.10B
Gross Margin42.1%
Op. Margin6.6%
ROE / Fwd P/E3.9% · 10.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HHS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HNI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 38.5%
IV Percentile 45th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HNI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HHS Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $30.0M market capitalization and -3.2% operating margin.
OpEx & R&D Reinvestment 19.3% of Rev ($30M)
90D Engineering Disclosures 0 Published
HNI Moat Profile Cyclical / Execution-Driven Positioning
Furnishings, Fixtures & Appliances Operator
Competes within the Furnishings, Fixtures & Appliances value chain with $3.5B market capitalization and 6.6% operating margin.
OpEx & R&D Reinvestment 35.5% of Rev ($744M)
90D Engineering Disclosures 0 Published

Investor FAQ HHS vs HNI Key Questions & Quantitative Answers

As of Nov 16, 2026, HNI Corporation (HNI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas HNI carries 49.8/100 (HOLD) at $48.48 (10.3x Forward P/E, 6.6% operating margin). Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. HNI 49.8/100 HOLD), HNI captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (6.6% vs. -3.2% operating margin) and revenue trajectory (+132.9% vs. -1.7% YoY).

HNI leads the Growth & Scale pillar: HHS posts -1.7% YoY revenue growth and -90.3% YoY earnings growth on $155M TTM revenue (16.1% gross margin, -3.2% operating margin), compared with HNI at +132.9% YoY revenue growth and +39.8% YoY earnings growth on $2.10B TTM revenue (42.1% gross margin, 6.6% operating margin). On trailing 12-month operating scale, HHS generates $155M in USD-normalized revenue versus $2.10B for HNI. In operating R&D and SG&A reinvestment, HHS deploys 19.3% of Rev ($30M) (0 90-day corporate R&D disclosures) versus 35.5% of Rev ($744M) (0 disclosures) for HNI.

HNI screens cheaper on headline valuation multiples. HHS trades at 14.3x Forward P/E, 14.3x Trailing P/E, 1.19x PEG, and 0.3x EV/Revenue (-2.9% FCF margin), whereas HNI trades at 10.3x Forward P/E, N/M Trailing P/E, 0.69x PEG, and 1.7x EV/Revenue (10.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HHS (-30.4% ROE) versus HNI (3.9% ROE) capital efficiency.

In options market volatility and institutional positioning, HHS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 46% Vol realized risk). By comparison, HNI carries 38.5% implied volatility (45th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.